209 related articles for article (PubMed ID: 28235063)
21. The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.
Zhao J; Fu W; Liao H; Dai L; Jiang Z; Pan Y; Huang H; Mo Y; Li S; Yang G; Yin J
BMC Cancer; 2015 Oct; 15():731. PubMed ID: 26482648
[TBL] [Abstract][Full Text] [Related]
22. Concise Review: LIN28/let-7 Signaling, a Critical Double-Negative Feedback Loop During Pluripotency, Reprogramming, and Tumorigenicity.
Farzaneh M; Attari F; Khoshnam SE
Cell Reprogram; 2017 Oct; 19(5):289-293. PubMed ID: 28846452
[TBL] [Abstract][Full Text] [Related]
23. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
24. Over-expression of cofilin-1 suppressed growth and invasion of cancer cells is associated with up-regulation of let-7 microRNA.
Tsai CH; Lin LT; Wang CY; Chiu YW; Chou YT; Chiu SJ; Wang HE; Liu RS; Wu CY; Chan PC; Yang MH; Chiou SH; Liao MJ; Lee YJ
Biochim Biophys Acta; 2015 May; 1852(5):851-61. PubMed ID: 25597880
[TBL] [Abstract][Full Text] [Related]
25. miRNA‑328 overexpression confers cisplatin resistance in non‑small cell lung cancer via targeting of PTEN.
Wang C; Wang S; Ma F; Zhang W
Mol Med Rep; 2018 Nov; 18(5):4563-4570. PubMed ID: 30221716
[TBL] [Abstract][Full Text] [Related]
26. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.
Xiao M; Cai J; Cai L; Jia J; Xie L; Zhu Y; Huang B; Jin D; Wang Z
J Ovarian Res; 2017 Apr; 10(1):24. PubMed ID: 28376831
[TBL] [Abstract][Full Text] [Related]
27. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
28. Lin28 promotes dental pulp cell proliferation via upregulation of cyclin-dependent proteins and interaction with let-7a/IGF2BP2 pathways.
Liu Y; Dong N; Miao J; Li C; Wang X; Ruan J
Biomed Pharmacother; 2019 May; 113():108742. PubMed ID: 30851545
[TBL] [Abstract][Full Text] [Related]
29. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
Huang RS; Zheng YL; Zhao J; Chun X
Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
[TBL] [Abstract][Full Text] [Related]
30. Lin28 Mediates Cancer Chemotherapy Resistance via Regulation of miRNA Signaling.
Xu C; Xie S; Song C; Huang L; Jiang Z
Hepatogastroenterology; 2014 Jun; 61(132):1138-41. PubMed ID: 26158177
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Lin28 inhibits the proliferation, migration and cell cycle progression and induces apoptosis of BGC-823 gastric cancer cells.
Song H; Xu W; Song J; Liang Y; Fu W; Zhu XC; Li C; Peng JS; Zheng JN
Oncol Rep; 2015 Feb; 33(2):997-1003. PubMed ID: 25515921
[TBL] [Abstract][Full Text] [Related]
32. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
33. Linc00221 modulates cisplatin resistance in non-small-cell lung cancer via sponging miR-519a.
Tang H; Han X; Li M; Li T; Hao Y
Biochimie; 2019 Jul; 162():134-143. PubMed ID: 31029744
[TBL] [Abstract][Full Text] [Related]
34. Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer.
Wang S; Pan H; Liu D; Mao N; Zuo C; Li L; Xie T; Huang D; Huang Y; Pan Q; Yang L; Wu J
Int J Oncol; 2015 Feb; 46(2):809-17. PubMed ID: 25434755
[TBL] [Abstract][Full Text] [Related]
35. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
36. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
37. Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cells.
Paz EA; LaFleur B; Gerner EW
Mol Carcinog; 2014 Feb; 53 Suppl 1():E96-106. PubMed ID: 23737330
[TBL] [Abstract][Full Text] [Related]
38. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
[TBL] [Abstract][Full Text] [Related]
39. β-Catenin/Lin28/let-7 regulatory network determines type II alveolar epithelial stem cell differentiation phenotypes following thoracic irradiation.
Liu X; Zhang T; Zhou J; Xiao Z; Li Y; Zhang Y; Yue H; Li Z; Tian J
J Radiat Res; 2021 Jan; 62(1):119-132. PubMed ID: 33302295
[TBL] [Abstract][Full Text] [Related]
40. Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.
Feng X; Liu H; Zhang Z; Gu Y; Qiu H; He Z
J Exp Clin Cancer Res; 2017 Sep; 36(1):123. PubMed ID: 28886730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
